Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Gene Therapy

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cgt.7700637PMID 14502231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

  2003cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB

  2002cited by this paper
• Cutting Edge: Targeted Ligation of CTLA-4 In Vivo by Membrane-Bound Anti-CTLA-4 Antibody Prevents Rejection of Allogeneic Cells1

  2002cited by this paper
• A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory

  2002cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002cited by this paper
• HLA class I antigen abnormalities and immune escape by malignant cells.

  2002cited by this paper
• Tuning tumor-specific T-cell activation: a matter of costimulation?

  2002cited by this paper
• The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

  2002cited by this paper
• Tumor gene therapy by MVA-mediated expression of T-cell–stimulating antibodies

  2002cited by this paper
• Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.

  2002cited by this paper
• Design of transgenes for efficient expression of active chimeric proteins on mammalian cells.

  2001cited by this paper
• The TCR Triggering Puzzle

  2001cited by this paper
• The TCR triggering puzzle.

  2001cited by this paper
• Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcγR scFv on cancer cell surface

  2001cited by this paper
• Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

  2001cited by this paper
• Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

  2001cited by this paper
• Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

  2001cited by this paper
• On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen.

  2001cited by this paper
• Characterization of the Major Histocompatibility Complex Class I Deficiencies in B 16 Melanoma Cells 1

  2001cited by this paper
• Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen

  2000cited by this paper
• Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition.

  2000cited by this paper
• B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity

  2000cited by this paper
• Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells

  2000cited by this paper
• Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.

  2000cited by this paper
• Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N-Glycosylation Is Essential for Maintenance of Receptor Surface Expression1

  2000cited by this paper
• Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells.

  1999cited by this paper
• In situ T cells in melanoma

  1999cited by this paper
• The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.

  1999cited by this paper
• Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth.

  1999cited by this paper
• Apoptosis of a human melanoma cell line specifically induced by membrane-bound single-chain antibodies.

  1999cited by this paper
• United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma.

  1998cited by this paper
• Cell surface expression of a human IgC Fc chimera activates macrophages through Fc receptors

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.

  1998cited by this paper
• Trends in cancer incidence and mortality in Scotland: description and possible explanations.

  1998cited by this paper
• Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

  1997cited by this paper
• B7-1-transfected tumor vaccine counteracts chemotherapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells

  1997cited by this paper
• Further evidence for a common mechanism for shedding of cell surface proteins

  1997cited by this paper
• A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy

  1997cited by this paper
• Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.

  1997cited by this paper
• B7‐1‐transfected tumor vaccine counteracts chemotherapy‐induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells

  1997cited by this paper
• Vaccination of tumor cells transfected with the B7‐1 (CD80) gene induces the anti‐metastatic effect and tumor immunity in mice

  1996cited by this paper
• Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.

  1996cited by this paper
• Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.

  1996cited by this paper
• Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma.

  1996cited by this paper
• Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors (*)

  1996cited by this paper
• Surface Expression of CD28 Single Chain Fv for Costimulation by Tumor Cells

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

  1995influential reference
• Fc receptor binding of anti‐CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine‐related side effects

  1995cited by this paper
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

  1994cited by this paper
• Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

  1993influential reference
• Immune Enhancers Composed of Polyvalent Binding Sites of Anti-CD3 Antibodies

  1993cited by this paper
• Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.

  1990cited by this paper
• O-linked glycosylation of rat renal gamma-glutamyltranspeptidase adjacent to its membrane anchor domain.

  1989cited by this paper
• Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein.

  1989cited by this paper

• Harnessing transcription factor activity for programmable therapeutic gene regulation

  2026cites this paper
• Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy

  2025cites this paper
• Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses

  2025cites this paper
• The interplay between membrane topology and mechanical forces in regulating T cell receptor activity

  2022cites this paper
• PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.

  2020cites this paper
• High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation

  2018cites this paper
• Tumor Immunotherapy by Gene-circuit Recruited Immunomodulatory Systems (TIGRIS) for Prostate Cancer

  2017influential citation
• Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.

  2017influential citation
• The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering

  2017cites this paper
• Surface expression of anti‐CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A‐engineered human umbilical cord mesenchymal stem cells

  2017cites this paper
• Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity

  2015cites this paper
• The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif

  2013cites this paper
• A unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene Glycol: A nondisplaceable property

  2011cites this paper
• Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models

  2011cites this paper
• Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule

  2010cites this paper
• Cutting Edge: Mechanical Forces Acting on T Cells Immobilized via the TCR Complex Can Trigger TCR Signaling

  2010cites this paper
• Can Trigger TCR Signaling T Cells Immobilized via the TCR Complex Cutting Edge: Mechanical Forces Acting on

  2010cites this paper
• The role of monocyte-derived cells in influenza-induced pathology and Th1 immune responses

  2009cites this paper
• In situ adenovirus vaccination engages T effector cells against cancer.

  2009cites this paper
• Tumor-Localized Ligation of CD3 and CD28 with Systemic Regulatory T-Cell Depletion Induces Potent Innate and Adaptive Antitumor Responses

  2009cites this paper
• Membrane‐tethered proteins for basic research, imaging, and therapy

  2008cites this paper
• Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes

  2007cites this paper
• Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.

  2007cites this paper
• Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin

  2007cites this paper
• Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored β-glucuronidase

  2007cites this paper
• A membrane antibody receptor for noninvasive imaging of gene expression

  2006cites this paper
• Hapten-directed targeting to single-chain antibody receptors

  2004cites this paper